Anthropic Acquires

• Anthropic a annoncé l'acquisition de Coefficient Bio, une startup américaine d'IA spécialisée dans la modélisation biologique, le 27 avril 2026. • L'opération vise à intégrer les outils d'IA de conception de protéines de Coefficient aux modèles Claude d'Anthropic pour des applications avancées de découverte de médicaments. • Cette initiative positionne Anthropic dans le secteur compétitif de l'IA-biotech alors que les investissements augmentent, accélérant potentiellement les percées en matière de médecine personnalisée.

• Anthropic expanded its AI strategy by acquiring AI drug discovery startup Coefficient Bio for approximately $400 million and launching a political action committee to influence AI regulation. • The company is also seeing surging investor demand for its shares amid tightening AI infrastructure supply and growing market appetite. • These moves position Anthropic to shape policy, enter life sciences, and capitalize on demand for leading AI technologies in the US.

• Anthropic acquired Coefficient Bio, a startup founded eight months ago with fewer than 10 employees, for roughly $400 million in shares, despite it having no product or revenue. • The platform uses AI for pharmaceutical tasks like drug research planning and identifying new drug opportunities, positioning Anthropic's models for scientific discovery in life sciences. • This bet signals a strategic push into AI-driven biotech, potentially accelerating drug development amid growing competition in applied AI verticals.